The federal government on Wednesday approved the sum of ₦9.99 billion for the procurement of antiretroviral (ARV) medicines for people living with HIV/AIDS ...

The federal executive council (FEC) presided by President Bola Tinubu has approved two memos from the ministry ...

FEC has approved N9.99 billion for the procurement of antiretroviral, ARV, medicines for people living with HIV/AIDS and the upgrade of cancer treatment facilities nationwide.

The Federal Executive Council (FEC), presided over by President Bola Ahmed Tinubu, on Wednesday approved two key health-sector proposals valued at about ₦10 billion to strengthen HIV treatment and ...

Nigeria's government approves N9.99bn in healthcare funding for HIV antiretroviral drugs and to upgrade six cancer treatment ...

As announced, Jaguar received an up-front payment of $16M of non-dilutive capital in January 2026 upon entering U.S.

Arvinas Inc. (NASDAQ: ARVN) is one of the best cancer stocks to invest in now. On February 24, Arvinas Inc. (NASDAQ:ARVN) delivered solid fourth-quarter and full-year results that affirmed progress ...

This week, the Malawi University of Science and Technology (Must) unveiled an ambitious K114 billion plan to establish a modern pharmaceutical manufacturing plant by 2028. According to Must deputy ...

Even with treatment interruption after initiation of antiretroviral therapy (ART) at birth, aviremia could still be maintained, leading to ART-free remission in children with HIV, according to results ...

Malawi University of Science and Technology (Must) has announced plans to start manufacturing antiretroviral drugs (ARVs) and other medicines locally to reduce dependence on imported medicines.

Q4 2025 earnings call recap: pipeline milestones, PROTAC FDA/PDUFA timeline, 2026 data catalysts, and cash runway—read now.

Q4 2025 Earnings Call February 24, 2026 8:00 AM ESTCompany ParticipantsJeff Boyle - Vice President of Investor RelationsRandy Teel ...